Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipitor for AVN Prevention in Lupus
NCT00412841Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- Nov 2002
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in avascular necrosis (AVN), sponsored by NYU Langone Health. Started Nov 2002; status: terminated.
02
Drugs
atorvastatin
03
Conditions
avascular necrosis (AVN)
Beyond the preview
Go deeper on NCT00412841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412841.